Medicaid patients continue high prescription opioid use after overdose

August 22, 2017, The JAMA Network Journals

Despite receiving medical attention for an overdose, patients in Pennsylvania Medicaid continued to have persistently high prescription opioid use, with only slight increases in use of medication-assisted treatment, according to a study published by JAMA.

For every fatal opioid , there are approximately 30 nonfatal overdoses. Nonfatal overdoses that receive represent intervention opportunities for clinicians to mitigate risk by reducing opioid prescribing or advocating addiction treatment. Studies evaluating commercially insured patients suggest these potential interventions are underutilized. Julie M. Donohue, Ph.D., of the University of Pittsburgh Graduate School of Public Health, and colleagues used 2008-2013 claims data for all Pennsylvania Medicaid enrollees ages 12 to 64 years with a heroin or prescription opioid overdose to compare prescription opioid use, duration of opioid use, and rates of medication-assisted treatment (MAT; buprenorphine, methadone, or naltrexone) before and after an overdose event.

The analysis included 6,013 patients with an overdose event (2,068 with a and 3,945 with a prescription opioid overdose). The researchers found that any filled opioid prescription decreased after overdose from 43.2 percent to 39.7 percent after heroin overdose, and from 66.1 percent before to 59.6 percent after prescription opioid overdose. The percentage of enrollees with 90 days or more duration of prescription opioids decreased in the heroin group (from 10.5 percent to 9 percent) and the prescription opioid group (from 32.5 percent to 28.3 percent). MAT increased after overdose from 29.5 percent to 33 percent and after prescription opioid overdose from 13.5 percent to 15.1 percent.

The authors write that these findings indicate "a relatively weak health system response to a life-threatening event. Several interventions have been shown to reduce overdose risk, including trigger notifications to clinicians for patients treated for overdose and emergency department-initiated naloxone education and distribution."

Study limitations include the focus on one state and the use of claims data, which may underestimate use by only tracking filled.

Explore further: Trump declares opioid crisis a 'national emergency'

More information: JAMA (2017). jamanetwork.com/journals/jama/ … .1001/jama.2017.7818

Related Stories

Trump declares opioid crisis a 'national emergency'

August 11, 2017
US President Donald Trump said Thursday that the opioid crisis in the United States constitutes a "national emergency" and pledged to step up efforts to fight the epidemic.

Access to naloxone eased in Louisiana, Utah

February 13, 2017
(HealthDay)—Health officials in Utah and Louisiana have issued orders to make naloxone more widely available in an effort to prevent overdose deaths, according to a report from the American Medical Association.

More Australians dying of accidental overdose of pharmaceutical opioids

July 24, 2017
In a reversal of the heroin epidemic of the late 90s and early 2000s, older Australians aged 35 to 54 are now more likely to die from an opioid overdose, a new report reveals.

How to obtain and use the 'angel' therapeutic Naloxone

July 18, 2017
It's a terrifying scenario that's become all-too-real in the age of the opioid epidemic: a person lying lifeless, not breathing, because of an opioid overdose.

Involvement of prescription opioids in fatal car crashes climbs sevenfold

July 26, 2017
The percentage of fatally injured drivers who tested positive for prescription opioids rose sevenfold from 1 percent in 1995 to over 7 percent in 2015, according to a new study at Columbia University's Mailman School of Public ...

Study examines polyneuropathy and long-term opioid use

May 22, 2017
Polyneuropathy is a common painful condition, especially among older patients, which can result in functional impairment.

Recommended for you

Shortcut strategy for screening compounds with clinical potentials for drug development

December 4, 2018
Developing a new drug often takes years and costs hundreds of millions of dollars. A shortcut has now been reported in a study led by City University of Hong Kong (CityU), which can potentially reduce the time and costs of ...

Drug wholesalers drove fentanyl's deadly rise, report concludes

December 4, 2018
Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug ...

Global review reports on administration of children's antibiotics

December 4, 2018
Researchers analyzing the sales of oral antibiotics for children in 70 high- and middle-income countries found that consumption varies widely from country to country with little correlation between countries' wealth and the ...

Opioid prescriptions from dentists linked to youth addiction risk

December 3, 2018
Teens and young adults who receive their initial opioid prescriptions from their dentists or oral surgeons are at increased risk for opioid addiction in the following year, a study from the Stanford University School of Medicine ...

Rise in meth and opioid use during pregnancy

November 29, 2018
Amphetamine and opioid use in pregnancy increased substantially over the last decade in the United States, a new Michigan Medicine-led study finds. And a disproportionate rise occurred in rural counties.

Mouse model aids study of immunomodulation

November 19, 2018
Because mice do not respond to immunomodulatory drugs (IMiDs), preclinical therapeutic and safety studies of the effects of IMiDs have not been possible in existing types of mice. This has led to an inability to accurately ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.